WHO ICTRP trial
Improvement of functional Outcome for patients with newly diagnosed grade 2 or 3…
EUCTR2018-005027-16-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2018-005027-16-DE |
|---|---|
| Public title | Improvement of functional Outcome for patients with newly diagnosed grade 2 or 3 glioma |
| Scientific title | Improvement of functional Outcome for patients with newly diagnosed grade 2 or 3 glioma with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial |
| Primary sponsor | Heidelberg University Hospital Represented in law by its Commercial Managing Director |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Germany |
| Conditions | WHO grade 2 or 3 glioma MedDRA version: 20.0 Level: PT Classification code 10018338 Term: Glioma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.1 Level: LLT… |
| Interventions | Product Name: Lomustine Pharmaceutical Form: Capsule Other descriptive name: LOMUSTINE Concentration unit: mg/m2 milligram(s)/square meter Concentration type: equal Pharmaceutical Form: Capsule INN or Proposed INN: PROCARBAZINE CAS Number… |
| Registration date | May 15, 2020 |
| Target size | 406 |
| Secondary IDs | NOA-18 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: